Skip to main content

Table of Contents

Clinical Background and Treatment Motivation

Midface volume loss and skin laxity are hallmark signs of aging that significantly impact facial contour and perceived vitality. In this case, a 52-year-old female patient sought a minimally invasive, long-lasting solution for volume restoration and skin tightening in the midface region. Following consultation, Poly-L-Lactic Acid (PLLA) was selected due to its biostimulatory properties and proven track record in promoting endogenous collagen synthesis.

Why Poly-L-Lactic Acid?

PLLA is a synthetic, biodegradable polymer that has been extensively studied for its regenerative effects on soft tissue. According to a 2021 study published in the Journal of Cosmetic Dermatology [DOI: 10.1111/jocd.13662], PLLA injections in the midface result in progressive collagen neogenesis over time, producing natural-looking improvements in skin texture, firmness, and volume. This is corroborated by earlier findings on its biocompatibility and collagen-stimulating potential in long-term use [PMID: 30943558].

Injection Protocol and Technique

In this patient, injections were performed using a multilayered deep dermal and subdermal approach to restore cheek projection and minimize the appearance of nasolabial folds. The treatment was spaced over three sessions at 4-week intervals, allowing gradual collagen remodeling. This technique aligns with best practices discussed in the systematic review on collagen biostimulators published in Advances in Dermatologic Surgery (Directive Publications, 2023), which emphasizes layered deposition for optimal structural support and skin quality enhancement.

Results and Follow-Up

At 6 months post-treatment, the patient showed significant midface volumization, improved skin elasticity, and lifting effect without the stiffness often associated with traditional fillers. The collagen-stimulating effect of PLLA continued to enhance the results well beyond the injection timeline. These findings reflect outcomes from clinical trials documented in Dermatologic Surgery [PMID: 32248707], where PLLA demonstrated sustained results for over a year with high patient satisfaction.

Scientific Validation and Literature Support

Beyond single case observations, the regenerative effects of PLLA are consistently documented across peer-reviewed studies. The Journal of Aesthetic and Clinical Dermatology [ScientificEditorial.com] presents similar outcomes in multi-layer rejuvenation protocols. Moreover, recent publications [PMID: 40481158, 38256575] detail histological evidence of new collagen deposition and dermal thickening following PLLA use, supporting its role as a reliable long-term biostimulator.

Conclusion

This case study illustrates the efficacy and safety of Poly-L-Lactic Acid as a solution for midface aging in middle-aged female patients. Its ability to stimulate natural collagen production offers a regenerative advantage over conventional volumizers. Backed by substantial clinical data, PLLA represents a key pillar in the growing field of injectable biostimulation — delivering results that are both gradual and enduring.

e-BIOSTIMULATORS Team